Patricia Carson is an intellectual property partner in the New York office of
Kirkland & Ellis LLP. She focuses her practice on patent litigation and
patent counseling matters, including IP due diligence and licensing. She
has experience prosecuting and licensing patents, as well as counseling
patent holders in a variety of fields. She counsels clients on patenting
strategy, patenting evaluation and IP due diligence relating to transactions,
including licensing, joint ventures and acquisitions. She has represented
clients in the pharmaceutical, biotechnology, chemical, medical device,
consumer healthcare, consumer electronics and semiconductor fields.
Prior to joining Kirkland, as a partner at Kaye Scholer, she won a major victory on behalf of Wyeth in Wyeth v. Kappos. The case successfully challenged the U.S. Patent and Trademark Office's interpretation of a statute designed to compensate patent holders for loss of patent term due to delays in processing applications. The victory resulted in significant patent term being added to the patents at issue in that case and to patents assigned to countless other companies as well. Patricia recently acted as lead counsel for Pfizer in Pfizer v. Watson, and defended the company against Watson's attempt to launch a generic version of Rapamune®, a drug used to prevent organ rejection in transplant patients.
Patricia has a scientific background and experience as a patent examiner. She holds a Ph.D. in microbiology and immunology from Temple University School of Medicine. She devoted several years to postdoctoral studies at the Medical College of Virginia and the National Institutes of Health. She also spent several years in the U.S. Patent and Trademark Office as a patent examiner in the biotechnology group.
Patricia has been recognized in The National Law Journal's "Defense Hot List" feature and by Intellectual Asset Management (IAM) Life Sciences 250 — The World's Leading Life Sciences Lawyers.
"Trial Strategies in the Era of the Troll," Corporate Counsel, September 7, 2010 Written Description, Chapter in Pharmaceutical and Biotech Patent Law, published by the Practising Law Institute, 2008